Singapore markets open in 4 hours 17 minutes
  • Straits Times Index

    3,173.82
    -0.09 (-0.00%)
     
  • S&P 500

    4,486.46
    +15.09 (+0.34%)
     
  • Dow

    35,258.61
    -36.15 (-0.10%)
     
  • Nasdaq

    15,021.81
    +124.47 (+0.84%)
     
  • BTC-USD

    61,267.20
    +1,560.00 (+2.61%)
     
  • CMC Crypto 200

    1,432.74
    -18.90 (-1.30%)
     
  • FTSE 100

    7,203.83
    -30.20 (-0.42%)
     
  • Gold

    1,764.50
    -3.80 (-0.21%)
     
  • Crude Oil

    82.35
    +0.07 (+0.09%)
     
  • 10-Yr Bond

    1.5840
    +0.0650 (+4.28%)
     
  • Nikkei

    29,025.46
    +474.56 (+1.66%)
     
  • Hang Seng

    25,409.75
    +78.75 (+0.31%)
     
  • FTSE Bursa Malaysia

    1,605.97
    +13.45 (+0.84%)
     
  • Jakarta Composite Index

    6,658.77
    +32.66 (+0.49%)
     
  • PSE Index

    7,219.81
    +36.70 (+0.51%)
     

Is Bristol Myers Squibb Stock a Buy?

·5-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Bristol Myers Squibb (NYSE: BMY) stock hasn't performed very well so far this year. In this Motley Fool Live video recorded on Sept. 15, Motley Fool contributors Keith Speights and Brian Orelli answer a viewer's question about whether or not the big pharma stock is a buy.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting